Wednesday, October 07, 2020 7:37:21 PM
Does Provectus have the capability with its patented PV10 technology to piggyback half-life radiotherapy on its platform to selectively kill cancers in the body? If so this is not just a one-trick pony show. We are looking at a billion-dollar company unfolding right before our eyes.